Humanin
- Category
- Longevity & Anti-Aging
- Administration routes
- Injectable
- Regulatory status
- Not FDA-approved
What it is
A 24-amino-acid peptide encoded by mitochondrial DNA, marketed for neuroprotection, metabolic support, and longevity. The evidence is almost entirely cell and animal work; there are no controlled human trials and essentially no human safety data. Its anti-apoptotic, STAT3-driven mechanism raises an unresolved concern about promoting existing cancers. Not an approved drug in the US, and supply is unregulated research-grade material of uncertain purity.
Read Full recordStudied uses & evidence
Studied uses(8)
Neuroprotection against Alzheimer's disease pathology
MediumConsistent animal and lab data show it shields neurons from Alzheimer's-related damage; no human trials yet.
Cytoprotection from apoptosis and oxidative stress
MediumIts most replicated effect, protecting many cell types from death and oxidative stress; still preclinical.
Diabetes and insulin signaling modulation
MediumAnimal studies plus human data linking lower humanin to impaired fasting glucose; no treatment trials yet.
Evidence limits
- Evidence Level
- Preclinical only
All evidence for humanin comes from in vitro cell studies and animal models (C. elegans, mice, rats, primates). No completed human clinical trials exist as of March 2026. Observational human data shows reduced CSF humanin in Alzheimer's patients (n=3) and elevated circulating humanin in children of centenarians. Naked mole-rats maintain stable humanin levels across their lifespan, unlike mice which show ~40% decline over 18 months.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
Do not use if
Active cancer
ModerateHumanin is anti-apoptotic — helps cells resist programmed death. May protect cancer cells from apoptosis in some contexts.
General cautions
Pregnancy
AbsoluteNo human reproductive safety data. Anti-apoptotic effects during fetal development are unpredictable.
Risk summary(6)
Risks = level of concern: High · Moderate · Low · Theoretical
No controlled human clinical trials; all safety from preclinical
HighAnti-apoptotic mechanism (Bax inhibition) may facilitate tumor progression in some cancers
ModerateSignals through STAT3, implicated in cancer progression
ModerateTransgenic humanin mice showed 46.5% decrease in litter size
LowTransgenic humanin mice showed 12% decrease in body length / 10.4% lower body weight
LowInjection site irritation (community reports)
Low
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.